Auro Pharma Revenue and Competitors

Auro Pharma Inc, is a Canadian subsidiary of Aurobindo Pharma Ltd. A fully integrated pharma company, Aurobindo Pharma features among the top 2 companies in India in terms of consolidated revenues. Aurobindo exports to over 150 countries across the globe with more than 90% of its revenues derived from international operations. Auro Pharma’s competitive advantage is in obtaining a large portfolio of product approvals backed up by a global standard R&D effort. It offers several non-patented, non-infringing processes with a cost-efficient mega manufacturing environment complying with US FDA, Health Canada, UKMHRA, TGA and EU authorities, Auro Pharma Inc. has over 150 NOCs in Canada. There are several more dossiers under Health Canada review. Auro Pharma is now gearing up to enter in various specialty segments starting 2022.